Innovation Pharmaceuticals Inc.
IPIX · OTC
6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -100% | – | -100% | – |
| Gross Profit | -$0 | $0 | -$0 | $0 |
| % Margin | – | 100% | – | 100% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | -36,355.6% | – | -1,422% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | -39,116.7% | – | -1,571.6% |
| EPS Diluted | -0.006 | -0.014 | -0.036 | -0.03 |
| % Growth | 55% | 61% | -21.7% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |